Publication:
COMPARISON OF THE TREATMENT EFFICACY OF RITUXIMAB AND PLASMAPHERESIS/INTRAVENOUS IMMUNOGLOBULIN COMBINATION WITH HISTORICAL CONTROL IN CHRONIC ANTIBODY MEDIATED REJECTION

dc.contributor.authorsRuhi, Caglar; TugCu, Murat; KasapogLu, Umut; Gokce, Ali Murat; Ata, PiNar; Titiz, IZzet Mesut
dc.date.accessioned2022-03-10T17:55:52Z
dc.date.accessioned2026-01-11T05:58:17Z
dc.date.available2022-03-10T17:55:52Z
dc.date.issued2017
dc.identifier.doidoiWOS:000411688503127
dc.identifier.eissn1432-2277
dc.identifier.issn0934-0874
dc.identifier.urihttps://hdl.handle.net/11424/221940
dc.identifier.wosWOS:000411688503127
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofTRANSPLANT INTERNATIONAL
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleCOMPARISON OF THE TREATMENT EFFICACY OF RITUXIMAB AND PLASMAPHERESIS/INTRAVENOUS IMMUNOGLOBULIN COMBINATION WITH HISTORICAL CONTROL IN CHRONIC ANTIBODY MEDIATED REJECTION
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPage301
oaire.citation.startPage300
oaire.citation.titleTRANSPLANT INTERNATIONAL
oaire.citation.volume30

Files